ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: A Mendelian randomization study: ACE inhibition and ACE2 expression (2020)
Attributed to:
An integrated genetic and proteomic approach to understanding cardiovascular disease aetiology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.59620
Publication URI: https://www.repository.cam.ac.uk/handle/1810/312523
Type: Journal Article/Review